Genmab — September 2020

[E_L]

they had a partnership with a small Danish company looooong time ago in infectious diseases, not even sure if that company still exists lol

[peter12]

ACE Biosciences acc to google. Genmab mention infectious disease when describing Duobody platform. Did they cooperate with Amgen about something similar ?

[gentogen]

Faldt lidt tilfældigt over denne gamle nyhed, som jeg ikke havde hørt om før: Tavotek Biotherapeutics Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab’s Proprietary DuoBody Technology Platform against a Pair of Disease Relevant Targets

[gentogen]

Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets

/PRNewswire/ -- Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered...

(www.prnewswire.com)

[peter12]

Den har været nævnt her før men lyder spændende

[Plimsoller]

God morgen

[Helge_LarsenPI-redaktør]

God morgen.

[Mogan]

God morgen

[Stroka]

Ikke megen chat i dag. Kursen klarer sig heldigvis fint uden.

[Helge_LarsenPI-redaktør]

DAX går pænt amok: https://www.proinvestor.com/investornyt/667649/dax-future-brager-op-gennem-12800-nu-3-i-dag

[E_L]

Large new ECOG-ACRIN trial, Dara Len Dex, adding Bortezomib in the consolidation phase only https://clinicaltrials.gov/ct2/show/NCT04566328?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=09%2F28%2F2020&draw=2&rank=3

[Sukkeralf]

A third wing of the biotech is working on protein-based therapies, including in programs that pair its technology with the potentially complementary capabilities of CRISPR Therapeutics and Genmab.

[Sukkeralf]

Just a moment...

(www.fiercebiotech.com)

[bibob]

Det var vel slet ikk så ring en daw.

[nohope]

Lidt har også ret.

[Solsen]

Det er super positivt, at vi nærmer os 2400. Der er ganske pæn underliggende styrke. Gad nok vide hvem der maser på og med hvilken begrundelse, som ikke analytikerne har fået øje på.

[transalp]

Go morgen..

[bibob]

God morgen. :-). FDA has granted PR for bb2121. https://www.onclive.com/view/fda-grants-priority-review-to-ide-cel-for-multiple-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=9-28-20_GIL-20-OGD0761_OncLiveSS_NHL CC eNews_Zydelig,Gilead_NON_US_Send&eKey=

[Helge_LarsenPI-redaktør]

Vincent Rajkumar
@VincentRK
Just out: Current Treatment Algorithms for Multiple Myeloma. Concise Guide to Treatment in Open Access Resource. Blood Cancer Journal. #BCJ @myelomaMD
@MayoClinic
@mtmdphd
@MayoCancerCare
@Rfonsi1
@NorthTxMSG
#myelomaVR

Full Text: https://nature.com/articles/s41408-020-00359-2

[Sukkeralf]

Flot comeback - mon det igen fokus rettes på den snart ekstremt flotte pipeline og høje forhåbninger til specielt PD-L1/4-1BB